Generated: May 29, 2017
|Title:||Pharmaceutical solution containing FK-506|
|Abstract:||A pharmaceutical solution which contains the compound of the general formula having the immusuppreseive activity is disclosed. ##STR1##|
|Inventor(s):||Nakanishi; Shigeo (Neyagawa, JP), Yamanaka; Iwao (Osaka, JP)|
|Assignee:||Fujisawa Pharmaceutical Co., Ltd. (Osaka, JP)|
Patent Claim Types:|
see list of patent claims
|Formulation; Compound; Process;|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Japan||2-51110||Mar 01, 1990|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||0444659||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.